Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Schaper

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Immunology|March 1, 2017
Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosusF Schaper, K de Leeuw, G Horst, et al.
The Journal of Biological Chemistry|January 9, 1999
Characterization and binding specificity of the monomeric STAT3-SH2 domainS Haan, U Hemmann, U Hassiepen, et al.
The Biochemical Journal|October 31, 1998
Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expressionF Schaper, C Gendo, M Eck, et al.
FEBS Letters|March 17, 1997
Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytesF Schaper, E Siewert, M J Gómez-Lechon, et al.
Biological Chemistry|December 1, 2001
The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcriptionJ G Bode, S Ludwig, C A Freitas, et al.
FEBS Letters|December 22, 1999
LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophagesJ G Bode, A Nimmesgern, J Schmitz, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Termination and modulation of IL-6-type cytokine signalingP C Heinrich, J Bode, M Decker, et al.
The EMBO Journal|November 4, 2000
The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3B Rödel, K Tavassoli, H Karsunky, et al.
Rural and Remote Health|December 25, 2012
Lungurra Ngoora--a pilot model of care for aged and disabled in a remote Aboriginal community--can it work?D C LoGiudice, K Smith, G Shadforth, et al.
The Biochemical Journal|March 23, 1999
Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptorS Thiel, I Behrmann, A Timmermann, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Immunology|March 1, 2017
Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosusF Schaper, K de Leeuw, G Horst, et al.
The Journal of Biological Chemistry|January 9, 1999
Characterization and binding specificity of the monomeric STAT3-SH2 domainS Haan, U Hemmann, U Hassiepen, et al.
The Biochemical Journal|October 31, 1998
Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expressionF Schaper, C Gendo, M Eck, et al.
FEBS Letters|March 17, 1997
Hepatocyte growth factor/scatter factor (HGF/SF) signals via the STAT3/APRF transcription factor in human hepatoma cells and hepatocytesF Schaper, E Siewert, M J Gómez-Lechon, et al.
Biological Chemistry|December 1, 2001
The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcriptionJ G Bode, S Ludwig, C A Freitas, et al.
FEBS Letters|December 22, 1999
LPS and TNFalpha induce SOCS3 mRNA and inhibit IL-6-induced activation of STAT3 in macrophagesJ G Bode, A Nimmesgern, J Schmitz, et al.
Advances in Experimental Medicine and Biology|January 5, 2002
Termination and modulation of IL-6-type cytokine signalingP C Heinrich, J Bode, M Decker, et al.
The EMBO Journal|November 4, 2000
The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3B Rödel, K Tavassoli, H Karsunky, et al.
Rural and Remote Health|December 25, 2012
Lungurra Ngoora--a pilot model of care for aged and disabled in a remote Aboriginal community--can it work?D C LoGiudice, K Smith, G Shadforth, et al.
The Biochemical Journal|March 23, 1999
Identification of a Leu-lle internalization motif within the cytoplasmic domain of the leukaemia inhibitory factor receptorS Thiel, I Behrmann, A Timmermann, et al.
Pageof 6